TEE-Guided Valve Implantation System
Summary
USPTO published patent application US20260096880A1 by Anumana, Inc. for a transesophageal echocardiogram-guided system that generates 3D cardiac models from ultrasound images to guide cardiovascular valve device implantation. The system includes TEE ultrasound components, computing devices for image processing and 3D model interpolation, and display capabilities for synchronized valve model visualization.
What changed
USPTO published patent application US20260096880A1 for a transesophageal echocardiogram-guided valve implantation system developed by Anumana, Inc. The system comprises a TEE ultrasound subsystem, a computing device that processes 2D ultrasound images into interpolated 3D cardiac models, valve model datum determination logic, and integrated display for overlaying valve device models onto patient-specific cardiac anatomy. The claimed invention addresses real-time image guidance for percutaneous valve procedures.
Medical device manufacturers developing cardiac valve products, structural heart intervention systems, or TEE-based imaging platforms should evaluate whether this published application could restrict freedom-to-operate in valve implantation technologies. Healthcare institutions performing transcatheter valve procedures may benefit from understanding emerging computational guidance tools that could enhance procedural planning and execution.
What to do next
- Monitor for future patent grant or rejection
- Review implications for competing cardiac device developers
- Assess potential licensing opportunities
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEM AND METHOD FOR TRANSESOPHAGEAL ECHOCARDIOGRAM-GUIDED IMPLANTATION OF A VALVE DEVICE
Application US20260096880A1 Kind: A1 Apr 09, 2026
Assignee
Anumana, Inc.
Inventors
Animesh Agarwal, Suthirth Vaidya, Rakesh Barve
Abstract
A system for transesophageal echocardiogram-guided implantation of a valve device, the system including at least a transesophageal echocardiogram system configured to detect at least an ultrasound image and at least a computing device configured to receive at least an ultrasound image, generate at least a 3D cardiac model representative of a heart of the patient as a function of at least an ultrasound image wherein the at least an ultrasound image includes a two-dimensional image of the heart of the patient and wherein the 3D cardiac model includes a three dimensional interpolation of the two-dimensional image, determine a valve model datum as a function of the 3D cardiac model, receive at least valve model representative of at least a cardiovascular device to be placed within the patient as a function of the valve model datum and display the at least a 3D cardiac model and at least a valve model.
CPC Classifications
A61F 2/2427 A61B 8/0883 A61B 8/12 A61B 8/466 A61B 8/5223 A61B 34/10 G16H 10/60 G16H 20/40 G16H 30/40 G16H 40/67 G16H 50/50 A61B 8/0841 A61B 2034/102 A61B 2034/2065 A61M 2025/0166
Filing Date
2025-02-06
Application No.
19047323
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.